William Blair has upgraded CVRx (NASDAQ:CVRX) to outperform from market perform, citing utilization improvements and ...

SoFi Technologies (NASDAQ:SOFI) and Affirm Holdings (NASDAQ:AFRM) were rising after William Blair initiated coverage of the ...

Enfusion (ENFN – Research Report) received a Hold rating and price target from William Blair analyst Dylan Becker today. The company’s shares ...

William Blair boosted their FY2024 earnings per share estimates for Certara in a research note issued on Wednesday, January 15th. William Blair analyst M. Smock now expects that the company will earn ...

William Blair last night initiated coverage of Sterling Infrastructure (STRL) with an Outperform rating. Sterling’s “industry-leading” data ...

Research analysts at William Blair dropped their FY2025 earnings estimates for shares of OneSpaWorld in a research report issued on Monday, January 13th. William Blair analyst S. Zackfia now ...

"It is my pleasure to welcome Terence to William Blair's Healthcare investment banking practice and its biopharma group," said Steve Tole, head of Healthcare investment bankin at William Blair. "Our ...

On Friday, Generation Bio Co (GBIO) stock saw a modest uptick, ending the day at $0.95 which represents no change from the prior close of of $0.95. The stock opened at $0.96 and touched a low of $0.94 ...

CHICAGO, January 07, 2025--(BUSINESS WIRE)--William Blair, the premier global boutique with expertise in investment banking, investment management, and private wealth management, has named Stewart ...

Neumora Therapeutics’ phase 3 fail was worse than analysts feared. | Neumora Therapeutics’ phase 3 fail was worse than ...

For investors looking for opportunities in fintech, SoFi presents an interesting case. Here's where analysts think the stock ...